Tag: HP-MAP
Vaxxas’ needle-free seasonal influenza vaccine enters clinical trial
Vaxxas has commenced the Phase I clinical trial of the first needle-free inactivated seasonal influenza vaccine quadrivalent (IIV4) candidate via its proprietary high-density microarray patch (HD-MAP) technology.
Featured Article
From ship repair to autonomous underwater vehicles: Griffin Industrial’s next chapter with growth capital
Some of Australia’s most critical manufacturing happens where almost no one sees it: inside a fuel tank on a Navy tanker, in a machine shop south of Perth, on a workshop floor in western Sydney where a team is helping build autonomous underwater vehicles. Griffin Industrial does all three.
